KLI

Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

Metadata Downloads
Publisher
BREAST CANCER RESEARCH AND TREATMENT
Language
영어
ISSN
0167-6806
Citation Volume
184
Citation Number
3
Citation Start Page
743
Citation End Page
753
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.